Results 211 to 220 of about 89,135 (337)
Identification and verification of the key genes involved in gallbladder cancer. [PDF]
Tang J +5 more
europepmc +1 more source
ABSTRACT Background Neuroendocrine neoplasms (NENs) constitute a heterogeneous group of rare tumors that most commonly originate from the gastrointestinal tract and lungs, with a consistently rising global incidence over recent decades. Hepatobiliary neuroendocrine neoplasms (HB‐NENs), defined as primary NENs arising in the liver and biliary tract, are
Xinlei Zhou +7 more
wiley +1 more source
A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer. [PDF]
Anthon C +11 more
europepmc +1 more source
Pharmacomicrobiomics is an emerging field due to important microbiome effects on pharmacokinetics and clinical outcomes. However, the application of this knowledge remains limited. Mycophenolic acid (MPA) is the primary active metabolite of the immunosuppressant, mycophenolate mofetil (MMF).
Abdelrahman Saqr +4 more
wiley +1 more source
National Cancer Database analysis of gallbladder cancer: Evaluating survival benefit of chemotherapy in early-stage gallbladder cancer. [PDF]
Kim M +5 more
europepmc +1 more source
ABSTRACT Background and Aims Breast cancer (BC) is the most often diagnosed malignancy in women. The genetic factor is estimated to be responsible for the higher BC risk. BC development is thought to be closely linked to the ESR1 gene, which controls cell division and proliferation.
Md. Shafiul Hossen +6 more
wiley +1 more source
Global gene expression landscape of gallbladder cancer and advances in targeted therapeutic strategies. [PDF]
Choudhury S +4 more
europepmc +1 more source
Gallbladder cancer in South America: epidemiology and prevention
Matias Salazar +4 more
openalex +1 more source
What's New? Boron neutron capture therapy (BNCT) is a targeted form of radiation therapy designed to selectively destroy cancer cells. BNCT is not widely used, however, owing in part to challenges involving selective boron delivery to tumors. The present study evaluated the potential of a novel glucoconjugate, 6‐O‐(o‐carboranylmethyl)‐d‐glucopyranose ...
Surachet Imlimthan +15 more
wiley +1 more source

